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Abstract
Transgender women of color are disproportionately impacted by HIV, poor health outcomes, and transgender-related dis-
crimination (TD). We tested the Model of Gender Affirmation (GA) to identify intervention-amenable targets to enhance 
viral suppression (VS) using data from 858 transgender women of color living with HIV (49% Latina, 42% Black; 36% 
virally suppressed) in a serial mediation model. Global fit statistics demonstrated good model fit; statistically significant 
(p ≤ 0.05) direct pathways were between TD and GA, GA and healthcare empowerment (HCE), and HCE and VS. Significant 
indirect pathways were from TD to VS via GA and HCE (p = 0.036) and GA to VS via HCE (p = 0.028). Gender affirmation 
and healthcare empowerment significantly and fully mediated the total effect of transgender-related discrimination on viral 
suppression. These data provide empirical evidence for the Model of Gender Affirmation. Interventions that boost gender 
affirmation and healthcare empowerment may improve viral suppression among transgender women of color living with HIV.
Keywords Transgender · HIV · Gender affirmation · Healthcare empowerment · Viral suppression
Introduction
Globally, transgender women are disproportionately 
impacted by HIV and transgender women living with 
HIV are less likely to be virally suppressed than other 
HIV-impacted groups [1]. Transgender women of color 
have also been shown to experience higher rates of vio-
lence, harassment, and discrimination than other subgroups 
of transgender people in the United States in virtually every 
aspect of life, such as employment, housing, and health-
care settings [2]. The association between discrimination 
and poor health outcomes has been documented but little is 
known about potential targets for intervention on this asso-
ciation. For example, experiences of discrimination among 
transgender people have been found to be correlated with 
higher rates of depression and post-traumatic stress disor-
der, both of which have been linked to lower rates of HIV 
medication adherence and negative health outcomes among 
people living with HIV [3–5]. Among transgender people, 
access to hormone therapy [6] and peer support [7] may 
buffer the effect of discrimination and stigma on health 
outcomes. The associations between social and medical 
gender affirmation with improved mental health outcomes 
have been documented but to date there is no quantitative 
data that explores how gender affirmation may mediate the 
relationship between discrimination and/or stigma and poor 
HIV-related health outcomes [5].
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The Model of Gender Affirmation is a transgender-spe-
cific conceptual framework developed to examine the role of 
gender affirmation in risk-taking, self-care, and healthcare-
seeking behavior among transgender women [8]. Gender 
affirmation has been defined as “an interpersonal, interac-
tive process whereby a person receives social recognition 
and support for their gender identity and expression” [8] 
and can also include medical and legal processes related to 
gender transition [9, 10]. Other terms that have been used 
to describe this concept include ‘gender validation’ [11] 
and ‘transgender identity affirmation’ [12]. The Model of 
Gender Affirmation was developed to explore gender affir-
mation-related dimensions of health disparities experienced 
by transgender people and to identify potential avenues for 
intervention upon the relationship between transgender-
related discrimination and negative health outcomes [8].
The Model of Gender Affirmation proposes that unmet 
need for gender affirmation in transgender persons can result 
in identity threat, which is the psychological threat to one’s 
sense of self that results from experiencing devaluation of 
one’s social group [13]. Transgender women whose needs 
for gender affirmation are not being met through social and 
medical pathways may attempt to reduce identity threat by 
seeking affirmation in contexts that pose risks and under-
mine health-seeking behaviors (e.g. risky sex, injection sili-
cone). The model hypothesizes that if identity threat can be 
reduced by meeting transgender people’s needs for gender 
affirmation through health-promoting means such as social 
support and gender-affirming medical care, health outcomes 
will improve. Preliminary support for the Model of Gender 
Affirmation demonstrates how meeting transgender women’s 
needs for gender affirmation may decrease risk behavior and 
increase self-care [8, 14, 15].
Given the complexities of multiple and unique barriers 
to engagement in HIV care experienced by transgender 
women living with HIV, the Model of Gender Affirmation 
was recently adapted to further inform intervention develop-
ment by integrating the concept of healthcare empowerment 
(HCE) [16–18]. The HCE model enables the organization, 
investigation, and intervention upon factors that contribute 
to optimal health outcomes and posits that vulnerable popu-
lations will experience improved health outcomes when they 
are informed, committed, collaborative, and engaged in their 
healthcare, and when they are able to tolerate uncertainty of 
future health outcomes. Studies have provided support for 
the HCE framework in explaining antiretroviral treatment 
(ART) uptake, adherence, and resulting viral suppression 
among non-transgender people living with HIV [16, 18–20]. 
The integration of the Model of Gender Affirmation with 
the Healthcare Empowerment Model results in a powerful 
and innovative conceptual framework for exploring inter-
vention-amenable factors that affect health outcomes from 
a perspective that is grounded in the unique cultural context 
of transgender women living with HIV.
The purpose of this paper is to present support for the 
construct of gender affirmation in the context of HIV-related 
health outcomes, with a particular emphasis on evaluating 
whether the adapted Model of Gender Affirmation fits the 
data from a large sample of transgender women of color 
living with HIV.
Methods
In 2012, the Health Resources and Services Administration, 
Special Projects of National Significance, funded the initia-
tive Enhancing Engagement and Retention in Quality HIV 
Care for Transgender Women of Color. Nine demonstration 
projects (four at community sites and five at clinical sites) 
in four urban centers (New York, Los Angeles, San Fran-
cisco Bay Area, and Chicago) were selected to develop and 
implement innovative interventions to engage and retain 
transgender women of color living with HIV in quality HIV 
care. An additional organization was funded to provide tech-
nical assistance to the demonstration projects and perform a 
multisite evaluation of the nine interventions. Details regard-
ing the initiative and the interventions have been previously 
published [21].
The demonstration sites designed their own recruitment 
strategies to reach and enroll participants into their interven-
tions. These strategies included community outreach, net-
working, word-of-mouth, publicity materials, and referrals 
from clinics and other service providers. To be eligible, one 
had to be 16 years or older, assigned male sex at birth, iden-
tify as transgender or female, diagnosed with HIV, and be 
fluent in English or Spanish. Enrolled individuals provided 
informed consent before participating in the study.
Before receiving the intervention, the participants visited 
the study site and took a self-administered baseline survey 
in REDCap [22] in the language of their choosing, either 
English or Spanish. As needed, sites had the option to have 
an interviewer administer the survey. The survey inquired 
about participants’ HIV care, health-related behaviors, and 
barriers and facilitators to care and is the source of the data 
for the present analyses. To compensate for their time and 
willingness to take the survey, participants received incen-
tives that varied between $25 and $50 across sites. The study 
was approved by the local Institutional Review Board at each 
of the demonstration sites as well as at the evaluation center.
Measures
Participants reported several demographic characteristics 
including age, race and ethnicity, and education.
AIDS and Behavior 
1 3
Healthcare empowerment was measured using the 4-item 
ICCE (informed, committed, collaborative, engaged) sub-
scale of the Healthcare Empowerment Inventory [16]. The 
Likert-type response options ranged from 1 (strongly dis-
agree) to 5 (strongly agree) with higher scores indicating 
greater healthcare empowerment. Sample item: ‘I try to get 
my healthcare providers to listen to my preferences for my 
treatment’; Cronbach alpha: 0.95.
Access to gender affirmation in healthcare was measured 
among participants who reported having ever received HIV 
primary care (see Online Appendix A). It was calculated 
as the mean score of 12 items developed for this purpose. 
The Likert-type response options range from 1 (least gender-
affirming HIV care) to 5 (most gender-affirming HIV care) 
with higher scale scores indicating more gender-affirming 
HIV care. Sample item ‘During your last HIV medical 
appointment, how welcoming was your medical care provid-
er’s waiting room for trans women?’ with response options 
ranging from 1 (not welcoming at all) to 5 (extremely wel-
coming); Cronbach alpha: 0.88.
Need for gender affirmation was measured by a 5-item 
measure developed specifically to measure this construct 
(see Appendix B). The items utilize Likert-type response 
options ranging from 1 (lowest need) to 5 (highest need). 
Higher mean scores indicate a greater need for gender affir-
mation. Sample item: ‘How important is it to you that stran-
gers call you “she” when talking about you?’ with response 
options 1 (not at all important) to 5 (extremely important); 
Cronbach alpha: 0.95.
Satisfaction with gender affirmation was measured using 
5 items developed specifically to measure this construct (see 
Online Appendix B). The items utilize Likert-type response 
options ranging from 1 (lowest satisfaction) to 5 (highest sat-
isfaction). Higher mean scores indicate greater satisfaction 
with gender affirmation. Sample item: ‘How satisfied are you 
with your current level of femininity?’ with response options 
1 (not at all satisfied) to 5 (extremely satisfied); Cronbach 
alpha: 0.87.
Experiences of transgender-related discrimination in 
the previous 6 months were recorded using five items—dis-
crimination from doctor or healthcare professional, denial 
of job, denial of health insurance, denial of housing oppor-
tunity and denial of bed in a homeless shelter [23]. The 
response options ranged from 0 (never) to 4 (many times). 
The response to each item was dichotomized into 0 (never) 
and 1 (at least once) mirroring the strategy used by the 
authors of the items. Sample item: ‘How many times in the 
last 6 months have you lost housing or been denied a housing 
opportunity because you are transgender?’ These five items 
were used to measure the latent construct of transgender-
related discrimination in the structural model.
Participants were categorized as being virally suppressed 
if their viral load had been tested in the previous 6 months 
and they self-reported having an undetectable viral load at 
the last test (using survey item: What is the result of your 
most recent viral load test? Response options: detectable, 
undetectable). Thus, viral suppression was a binary variable 
(1: virally suppressed; 0: not virally suppressed).
Data Analysis
We studied the missing data patterns in the variables of 
interest, as participants were allowed to decline to answer 
questions and some participants did not complete their 
survey. We found that 35 participants had not responded 
to any of the items that measured transgender-related dis-
crimination, gender affirmation, and healthcare empower-
ment. These participants were dropped from the analyses. 
Descriptive statistics for the sample were then generated 
using SAS V9.4 software [24]. All further analyses were 
performed in Mplus 8 [25]. We then used structural equa-
tion modeling (SEM) to test the direct as well as indirect 
effects of transgender-related discrimination, gender affir-
mation and healthcare empowerment on viral suppression 
(Fig. 1). Transgender-related discrimination was modeled as 
a latent variable measured by the five binary items described 
in “Measures” section above. The latent variable gender 
affirmation was measured by: need for gender affirmation, 
satisfaction with gender affirmation, and access to gender 
affirmation in healthcare. Based on previous findings in lit-
erature, sociodemographic characteristics of age, race/eth-
nicity and education were also included in the hypothesized 
model.
We used multiple imputation to create 50 complete 
datasets to handle the missing data, assumed to be miss-
ing-at-random (MAR). The SEM was fit using the two-
stage process [26]. In the first stage, the measurement 
model was fit to ensure satisfactory measurement of the 
constructs. This was done by evaluating the relationship 
between each latent factor and its constituent observed 
variables, the correlations among the constructs and the 
overall model fit. In the second stage, the full hypoth-
esized structural model was tested with an emphasis on 
the direct and indirect paths between constructs and the 
model fit. Diagonally weighted least squares estima-
tion suitable for binary and ordinal data was used due to 
the presence of categorical variables (Mplus estimator 
WLSMV) [27]. In both stages, for both the latent fac-
tors, their measurement scale was determined by fixing 
the first constituent observed variable’s factor loading to 
1.00. We report both unstandardized regression coeffi-
cients (B) and standardized regression coefficients (β) 
for each effect. At each stage, exact model-data fit was 
evaluated by the Chi square test of exact fit. Because 
the Chi square test is sensitive to trivial departures from 
perfect model-data fit [28], the approximate model fit 
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was assessed using Bentler’s [29] Comparative Fit Index 
(CFI), the root mean square error of approximation 
(RMSEA), and the weighted root mean square residual 
(WRMR). The model is said to fit the data on an approxi-
mate basis if two of the following three conditions are 
met: CFI ≥ 0.95, RMSEA < 0.06, and WRMR < 1.00 [30, 
31].
Results
Between December 2013 and August 2016, the nine 
demonstration sites recruited a total of 858 transgender 
women of color living with HIV. After removing 35 indi-
viduals’ data (see “Data Analysis” section above) from 
the total sample, the current analysis dataset consisted 
of 823 women. The average age was 37 years (Table 1). 
Approximately half (49%) were Hispanic/Latina, 42% 
were Black and 8% reported their race–ethnicity as 
one of American Indian/Alaska native, Asian/Pacific 
Islander or multi-racial. Less than a quarter of the sam-
ple (22%) indicated some college education and three 
quarters reported annual incomes less than the Federal 
Poverty Level ($11,490). Sources of transgender-related 
discrimination varied; 131 participants (16%) reported 
being denied health insurance and 302 participants (37%) 
reported being denied a job.
Measurement Model
In the measurement model, all factor loadings between the 
latent factors and their observed variables were significant at 
p < 0.001. Transgender-related discrimination was negatively 
correlated with gender affirmation, healthcare empowerment 
and viral suppression (Table 2). Viral suppression, gender 
affirmation and healthcare empowerment were positively 
correlated with each other. All factor intercorrelations were 
significant (p < 0.01), except between transgender-related 
discrimination and viral suppression (p = 0.064). The meas-
urement model fit the data satisfactorily: χ2(60) = 190.10; 
CFI = 0.95, RMSEA = 0.05; WRMR = 1.38.
Structural Model
The structural model with the estimated standardized 
path coefficients is illustrated in Fig. 1. The results pre-
sented are those averaged over the 50 imputed datasets. 
The estimates and standard errors for each measurement 
and structural path is shown in Table 3. Significant posi-
tive direct effects were observed from gender affirmation 
to healthcare empowerment and healthcare empowerment 
to viral suppression. A significant negative direct effect 
was observed from transgender-related discrimination to 
gender affirmation. The only three non-significant direct 
effects in the structural model were from transgender-
related discrimination to healthcare empowerment and 
0.76***
0.91***
0.17***
0.75*** Transgender-relatedDiscriminaon
-0.07 Viral
Suppression
-0.09*
0.89*** -0.04 0.08
0.14*
-0.24* 0.18*
0.84***
0.14***
Gender Affirmaon 0.37***
0.43*** 0.46***
0.61***
Degree of GA in 
Healthcare
Sasfacon with GANeed for GA
Healthcare 
Empowerment
College
Black
Age
Denied bed in a 
homeless shelter
Lost or denied housing
Denied job opportunity
Denied enrollment in 
health insurance plan
Discriminaon from 
healthcare professional
Fig. 1  Structural equation model for transgender women of color 
living with HIV, depicting paths and standardized estimates among 
transgender-related discrimination, gender affirmation, healthcare 
empowerment and viral suppression (N = 823). The coefficients on 
the arrows from ‘transgender-related discrimination’ to each form of 
discrimination, and from ‘gender affirmation’ to its constituents, are 
the standardized factor loadings of each item on to the latent factor. 
*p < 0.05, ***p < 0.001 for coefficients
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viral suppression and from gender affirmation to viral 
suppression. With regards to the sociodemographic con-
trol variables, while age and education demonstrated sig-
nificant positive direct effects on viral suppression, being 
Black showed a significant negative direct effect. The total 
indirect effect from discrimination to viral suppression was 
significant (B = − 0.06, p = 0.03, β = − 0.04). The specific 
indirect effect from discrimination to viral suppression 
via gender affirmation and healthcare empowerment was 
significant (B = − 0.02, p = 0.02, β = − 0.02), whereas 
the specific indirect effects from discrimination to viral 
suppression via gender affirmation (B = − 0.03, p = 0.27, 
β = − 0.02) and from discrimination to viral suppression 
via healthcare empowerment were both non-significant 
(B = − 0.009, p = 0.42, β = − 0.007). The indirect effect 
from gender affirmation to viral suppression via healthcare 
empowerment was also significant (B = 0.13, p = 0.003, 
β = 0.07). Therefore, in the present hypothesized model, 
while the variability in viral suppression (R-square = 0.13) 
can be explained by the direct influence of healthcare 
empowerment, it can also be explained by gender affir-
mation via healthcare empowerment and by transgender-
related discrimination via gender affirmation and health-
care empowerment together. In fact, gender affirmation in 
combination with healthcare empowerment significantly 
and fully mediated the total effect of transgender-related 
discrimination on viral suppression. The model fit the 
data well: χ2(57) = 160.76; RMSEA = 0.047, CFI = 0.958, 
WRMR = 1.307.
Table 1  Descriptive characteristics of participants (N = 823)
Demographic characteristics
 Age [in years; mean (SD)] 37.4 (10.8)
n (%)
 Race–ethnicity
  Hispanic, Latina or of Spanish origin 406 (49)
  Black, non-Hispanic 349 (42)
  Other, non-Hispanic 68 (8)
 Education: at least some college or higher 183 (22)
Study measures
 Viral suppression 303 (37)
 Experiences of discrimination in past 6 months
  Discrimination from doctor or healthcare professional 191 (23)
  Denied enrollment in health insurance plan 131 (16)
  Denied a job opportunity 302 (37)
  Lost or denied housing 232 (28)
  Denied bed in a homeless shelter 190 (23)
Mean Std Dev
 Need for gender affirmation 3.98 (1.2)
 Satisfaction with gender affirmation 3.45 (1.1)
 Degree of gender affirmation in healthcare 3.75 (0.8)
 Healthcare empowerment 3.87 (1.1)
Table 2  Correlation matrix 
of measurement model latent 
factors and viral suppression
N = 823. Correlations were generated in Mplus 8 (Mplus estimator WLSMV)
** p < 0.01; *** p < 0.001
Measure 1. Discrimination 2. Gender 
affirmation
3. Health care 
empowerment
4. Viral 
suppres-
sion
1. Discrimination 1.00
2. Gender affirmation − 0.24*** 1.00
3. Health care empowerment − 0.12** 0.39*** 1.00
4. Viral suppression − 0.09 0.17** 0.25*** 1.00
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Discussion
Our findings provide support for an adapted Model of 
Gender Affirmation with a large sample of transgender 
women of color in the US living with HIV. We found that 
gender affirmation in combination with healthcare empow-
erment significantly and fully mediated the total effect 
of transgender-related discrimination on viral suppres-
sion; that is, the negative association between transgen-
der-related discrimination and viral suppression can be 
explained by the direct influence of gender affirmation 
and healthcare empowerment. Thus, when participants 
reported experiencing transgender-related discrimination, 
viral suppression was more likely to be achieved when 
higher levels of gender affirmation and healthcare empow-
erment were also reported.
When the Model of Gender Affirmation was first pro-
posed, it was conceptualized as having two distinct dimen-
sions—need for gender affirmation and access to gender 
affirmation—which were hypothesized to vary indepen-
dently. In the final model presented here, gender affirma-
tion was measured by a latent variable with three observed 
indicators—need for gender affirmation, satisfaction with 
gender affirmation, and access to transgender-competent 
care. All three variables were positively associated with 
one another. In contrast to previous research, we found 
support for the hypothesis that experiences of discrimina-
tion are negatively associated with healthcare empower-
ment. This finding may be attributable to the larger sample 
size we attained compared to previous studies that did not 
detect this association [32].
Table 3  Unstandardized estimates, standard errors, and standardized estimates for structural equation model of experiences of transgender dis-
crimination, gender affirmation, healthcare empowerment and viral suppression (N = 823)
Estimates and associated statistics were generated in Mplus 8 (Mplus estimator WLSMV) based on 50 imputed datasets
D discrimination, GA gender affirmation, HCE healthcare empowerment, VS viral suppression, B unstandardized regression coefficient, SE 
standard error of B, β standardized regression coefficient
*p < 0.05; ***p < 0.001
Outcome variable Explanatory variable B S.E. β
Measurement coefficients
 D1. Discrimination from doctor or healthcare professional Discrimination 1.000 – 0.762
 D2. Denied enrollment in health insurance plan Discrimination 1.188*** 0.062 0.905
 D3. Denied job opportunity Discrimination 0.985*** 0.055 0.750
 D4. Lost or denied housing Discrimination 1.163*** 0.057 0.885
 D5. Denied bed in a homeless shelter Discrimination 1.101*** 0.056 0.839
 GA1. Need for gender affirmation Gender Affirmation 1.000 – 0.430
 GA2. Satisfaction with gender affirmation Gender Affirmation 1.250*** 0.186 0.614
 GA3. Degree of gender affirmation in healthcare Gender Affirmation 0.731*** 0.152 0.455
Structural coefficients—direct effects
 Gender affirmation Discrimination − 0.162* 0.047 − 0.239
 Healthcare empowerment Discrimination − 0.054 0.067 − 0.037
 Healthcare empowerment Gender affirmation 0.81*** 0.140 0.372
 Viral suppression Gender affirmation 0.169 0.148 0.084
 Viral suppression Discrimination − 0.088 0.073 − 0.065
 Healthcare empowerment Education 0.379*** 0.099 0.140
 Viral suppression Healthcare empowerment 0.164* 0.048 0.179
 Viral suppression Age 0.016*** 0.004 0.165
 Viral suppression Black − 0.187* 0.094 − 0.089
 Viral suppression Education 0.353* 0.106 0.142
Structural coefficients—indirect effects
 Total indirect: D → VS − 0.058* 0.026 − 0.043
  Specific indirect
   D → GA → HCE → VS − 0.022* 0.010 − 0.016
   D → GA → VS − 0.027 0.025 − 0.020
   D → HCE → VS − 0.009 0.011 − 0.007
 Total and specific indirect: GA → HCE → VS 0.133* 0.045 0.066
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It has been extensively documented that discrimination 
in healthcare settings is a major barrier to achieving and 
maintaining viral suppression among transgender women 
[23, 33]. In addition, our model provides evidence that dis-
crimination from other sources such as employment, health 
insurance and housing also impact viral suppression. The 
pervasive discrimination that transgender women experience 
regularly, and from multiple sources, creates intersecting 
structural barriers that result in persistent health disparities. 
From a clinical perspective, our findings suggest that gender-
affirming and empowering care from a knowledgeable and 
culturally competent provider is important to interrupt this 
association between transgender-related discrimination and 
negative health outcomes.
Gender affirmation on its own did not lead directly to 
viral suppression indicating that the context of empower-
ment within healthcare is important for affirmation to result 
in improved HIV-related health outcomes. The impact of 
lack of empowerment within healthcare on health outcomes 
may be difficult to overcome even in the context of gender 
affirmation. Social and behavioral interventions designed 
to increase access to gender affirmation and healthcare 
empowerment may improve rates of viral suppression among 
transgender women of color living with HIV.
Strengths of this study include the use of data from a 
large national study of transgender women of color living 
with HIV in which recruitment occurred at both clinical and 
non-clinical urban sites. However, enrollment was limited to 
transgender women of color by design and the sample was 
predominantly low-income; therefore, findings cannot be 
directly generalized to transgender women from rural areas, 
those who are White, or those have a higher socioeconomic 
status. Because this study utilized a convenience sample and 
cross-sectional analyses, no causal inferences can be drawn. 
Further, this study used measures of gender affirmation that 
have not yet been validated; future research will seek to vali-
date these scales.
These data provide empirical evidence to support the 
Model of Gender Affirmation, which lays the conceptual 
foundation for intervention development to improve health 
outcomes among transgender women of color living with 
HIV. Gender affirmation and healthcare empowerment are 
important components of any health promotion intervention 
that seeks to improve health outcomes among transgender 
women living with HIV.
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